CareDx
CDNA
147 hedge funds and large institutions have $644M invested in CareDx in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 54 reducing their positions, and 28 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
83% more call options, than puts
Call options by funds: $381K | Put options by funds: $208K
65% more capital invested
Capital invested by funds: $391M → $644M (+$253M)
7% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 28
2% less funds holding
Funds holding: 150 → 147 (-3)
3.87% less ownership
Funds ownership: 102.97% → 99.1% (-3.9%)
13% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$7.36M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.22M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.42M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.19M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$14.3M |
| 2 |
State Street
Boston,
Massachusetts
|
-$7.48M |
| 3 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$6.2M |
| 4 |
RA
Royce & Associates
New York
|
-$5.88M |
| 5 |
Squarepoint
New York
|
-$2.77M |
CDNA Hedge Fund Activity: Q4 2023 in Review
147 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q4 2023, worth a combined $644M — up 65% from $391M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CDNA and 26 opened new positions — a net loss of 2 holders — while 54 trimmed existing stakes and 47 added.
The largest buyer was Morgan Stanley, adding an estimated $7.36M. The largest seller was Armistice Capital, exiting entirely with an estimated $14.3M sold.
- 147 institutional investors held CareDx (CDNA) as of Q4 2023, down from 150 in Q3 2023.
- Funds reported $644M of CareDx stock for Q4 2023, up 65% quarter-over-quarter.
- 26 funds opened new CareDx positions in Q4 2023 and 28 closed out, a net change of -2 holders.
- The largest CareDx buyer in Q4 2023 was Morgan Stanley, an estimated $7.36M added.
- The largest CareDx seller in Q4 2023 was Armistice Capital, an estimated $14.3M sold.
Based on aggregated 13F filings for Q4 2023.